LYPD5 and pancreatic neoplasm: KLF13 was confirmed to inhibit the EMT process of pancreatic cancer by promoting the transcription of LINC00261 and suppressing the expression of metastasis-associated proteins, thus, inhibiting the metastasis of pancreatic cancer [131].